Wedbush Securities Inc Phio Pharmaceuticals Corp. Transaction History

Wedbush Securities Inc

  • $2.7 Billion
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Oct 20, 2020
SELL
$1.95 - $2.94 $65,079 - $98,119
-33,374 Closed
0 $0
Q2 2020

Jul 16, 2020
BUY
$1.68 - $3.05 $56,068 - $101,790
33,374 New
33,374 $73,000

Others Institutions Holding PHIO

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0
View Full List

About Phio Pharmaceuticals Corp.

PHIO Quotes by TradingView
  • Ticker PHIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 13,658,700
  • Market Cap $25M
  • Description
  • Phio Pharmaceuticals Corp. develops immuno-oncology therapeutics in the United States. It offers INTASYL therapeutic platform focuses on targeting tumor and immune cells by regulating genes of the immune system. The company develops PH-762 that activates immune cells to recognize and kill cancer cells by reducing the expression of the checkpoint...
More about PHIO
Track This Portfolio

Track Wedbush Securities Inc Portfolio

Follow Wedbush Securities Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wedbush Securities Inc, based on Form 13F filings with the SEC.

News

Stay updated on Wedbush Securities Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email